TELL ME MORE
ABOUT THIS CLINICAL TRIAL FOR PSORIATIC ARTHRITIS IN ADULTS
This is a Phase IV Comparitor Study of an Investigational Medicine to Evaluate its Superiority over Methotrexate after 16 weeks of Treatment, Followed by long-term Maintenance up to 52 Weeks, on Minimal Disease Activity (MDA) in Adult Methotrexate-naive and Biologic-naive Subjects with Active Psoriatic Arthritis
[contact-form-7 id=”2066″ title=”Study Contact Form – Psoriatic Arthritis”]
Clinical Trial for Psoriatic Arthritis in Adults
Study Location(s): Evansville Indiana – Rheumatology, Arthritis and Immunology Clinic
Psoriatic arthritis is a chronic, inflammatory disease of the joints and the places where tendons and ligaments connect to bone. The immune system creates inflammation that can lead to swelling, pain, fatigue and stiffness in the joints. PsA can start at any age, but often appears between ages 30 and 50. For most people, it starts about 10 years after psoriasis begins. This is a comparison study to evaluate an investigational medicine for Psoriatic Arthritis in adults with active disease and who are methotrexate-naive and biologic-naive to on-going treatment. Click here for more information on living with Psoriatic Arthritis.
There is no cost to participate. Volunteers receive free investigational medicine and follow-up care. No insurance needed. Time and travel reimburrsement up to $900 may be available.